Please login to the form below

Not currently logged in
Email:
Password:

Mission Therapeutics

This page shows the latest Mission Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Biomedical Catalyst funding 'must continue', says BIA

Biomedical Catalyst funding 'must continue', says BIA

macular degeneration (AMD), almost £3m for a Kings College London research team developing a T cell therapy for Crohn's disease and £1.9m for Cambridge start-up MISSION Therapeutics to

Latest news

  • Janssen launches EMEA division to market hepatitis C drug

    Janssen launches EMEA division to market hepatitis C drug. Janssen Therapeutics EMEA will be based in Beerse, Belgium. ... Janssen Therapeutics EMEA is on a mission to bring new options to successfully treat patients with this devastating disease.”.

  • GSK forms alliance with Epizyme

    The therapeutics would work by controlling the pathways of gene expression that contribute to diseases. ... Dr Robert Gould, CEO and president of Epizyme, said: "Epizyme's mission is to develop personalised therapeutics for genetically-defined patients

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Dr Colin Goddard appointed chairman at Mission Therapeutics Dr Colin Goddard appointed chairman at Mission Therapeutics

    Dr Colin Goddard appointed chairman at Mission Therapeutics. Will take up the role at the Cambridge, UK firm in January. ... Mission Therapeutics has appointed Dr Colin Goddard as its non-executive chairman, a role he will take up on January 1.

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    She joins from PsiOxus Therapeutics where she served as chief financial officer, and has also held a number of positions at Cytomyx Holdings, OrthoMimetics, and Mission Therapeutics. ... ambitious plans to create a high value pipeline of differentiated

  • Mission Therapeutics appoints new chief financial officer Mission Therapeutics appoints new chief financial officer

    Mission Therapeutics appoints new chief financial officer. David Luther joins with 25 years healthcare and pharmaceutical experience. ... Cambridge, UK-based Mission Therapeutics has appointed David Luther as chief financial officer.

  • MISSION appoints Paul Wallace as chief business officer MISSION appoints Paul Wallace as chief business officer

    MISSION appoints Paul Wallace as chief business officer. Joins from Medivir where he was executive VP and head of business development. ... Cancer biotech MISSION Therapeutics has named Paul Wallace as chief business officer.

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics